Cargando…

Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma

BACKGROUND: The present paper evaluates the genetic variability of HCV in patients with hepatocellular carcinoma (HCC). METHODS: Amino acid substitutions (aas) in NS3, NS5A and core regions were analyzed in 17 patients with HCC (Cases) and 13 without HCC (Controls), all naïve to DAAs. For the Cases,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pisaturo, Mariantonietta, Di Fraia, Alessandra, Occhiello, Laura, Minichini, Carmine, Starace, Mario, Iodice, Valentina, Farella, Nunzia, Stanzione, Maria, Coppola, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665876/ https://www.ncbi.nlm.nih.gov/pubmed/34908854 http://dx.doi.org/10.2147/IDR.S337647

Ejemplares similares

Virological Factors Associated with Failure to the Latest Generation of Direct Acting Agents (DAA) and Re-Treatment Strategy: A Narrative Review
por: Onorato, Lorenzo, et al.
Publicado: (2021)

Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study
por: Coppola, Nicola, et al.
Publicado: (2016)

Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy
por: Alessio, Loredana, et al.
Publicado: (2018)

Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf
por: Coppola, Nicola, et al.
Publicado: (2017)

Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2
por: Russo, Antonio, et al.
Publicado: (2020)

Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report
por: Calò, Federica, et al.
Publicado: (2022)

Hepatitis D virus infection in a large cohort of immigrants in southern Italy: a multicenter, prospective study
por: Pisaturo, Mariantonietta, et al.
Publicado: (2022)

Correction: Hepatitis D virus infection in a large cohort of immigrants in southern Italy: a multicenter, prospective study
por: Pisaturo, Mariantonietta, et al.
Publicado: (2023)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
por: Sagnelli, Evangelista, et al.
Publicado: (2012)

Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV Infection
por: Coppola, Nicola, et al.
Publicado: (2018)

Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features
por: Coppola, Nicola, et al.
Publicado: (2017)

Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis
por: Mariantonietta, Pisaturo, et al.
Publicado: (2019)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
por: Pisaturo, Mariantonietta, et al.
Publicado: (2019)

Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review
por: Russo, Antonio, et al.
Publicado: (2020)

Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease †
por: Alessio, Loredana, et al.
Publicado: (2022)

Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
por: Coppola, Nicola, et al.
Publicado: (2014)

HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
por: Piermatteo, Lorenzo, et al.
Publicado: (2021)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
por: Messina, Vincenzo, et al.
Publicado: (2020)

Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
por: Sagnelli, Caterina, et al.
Publicado: (2019)

Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma
por: Tortora, Raffaella, et al.
Publicado: (2023)

Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
por: Coppola, Nicola, et al.
Publicado: (2012)

Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients
por: Sagnelli, Caterina, et al.
Publicado: (2017)

Epidemiology and management of hepatitis C virus infections in immigrant populations
por: Coppola, Nicola, et al.
Publicado: (2019)

Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study
por: Pisaturo, Mariantonietta, et al.
Publicado: (2021)

Early predictors of clinical deterioration in a cohort of outpatients with COVID‐19 in southern Italy: A multicenter observational study
por: Monari, Caterina, et al.
Publicado: (2022)

Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Onorato, Lorenzo, et al.
Publicado: (2021)

Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort)
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2020)

Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology?
por: Nevola, Riccardo, et al.
Publicado: (2022)

COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
por: Sagnelli, Caterina, et al.
Publicado: (2022)

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype
por: Sagnelli, Caterina, et al.
Publicado: (2016)

Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens
por: Martini, Salvatore, et al.
Publicado: (2023)

Screening for HCV infection combined with SARS-CoV-2 vaccination in the Campania region
por: Torre, Pietro, et al.
Publicado: (2022)

Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression
por: Coppola, Nicola, et al.
Publicado: (2013)

Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C
por: Coppola, Nicola, et al.
Publicado: (2014)

Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern Italy
por: Pisaturo, Mariantonietta, et al.
Publicado: (2021)

HCV Genome-Wide Genetic Analyses in Context of Disease Progression and Hepatocellular Carcinoma
por: Donlin, Maureen J., et al.
Publicado: (2014)

Associated screening for HCV and SARS‐Cov2 infection in an urban area of Southern Italy: A cohort study
por: Coppola, Carmine, et al.
Publicado: (2021)

Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients
por: Di Stefano, Mariantonietta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ai51r37ktg3fvkj1mp42mo6bsu